Discover the Latest in Adherence Tech The Latest

It is widely accepted that patients participating in clinical trials are less than perfectly compliant with their medication regimens. The extent to which non-compliance affects the results of clinical trials […]

The problem of having patients determine their own dosing during clinical trials is widely recognized. If data obtained in clinical trials where patients take medication once or twice a day […]

Clinical trial costs are spiralling out of control. Studies generally estimate the cost of bringing an Investigational new drug (IND) to market at $1B although there is considerable variability in […]

“At some point, perhaps not in the far future, it will seem as wrong to run a clinical trial without compliance measurement as without randomization.” B. Efron, Statistics in Medicine, 1998 […]

The classical approach to decision-making in clinical research is the randomized trial. Patients are assigned to treatment conditions according to sample sizes that are determined a priori by power calculations. […]

A Risk Evaluation and Mitigation Strategy (REMS) is an FDA-mandated approach to ensuring the safety of medications. The baseline for ensuring the safe use of prescribed medication is professional labelling. […]